Macquarie Group Portfolio holdings
AUM
$81.5B
This Quarter Return
+2.34%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$54.7B
AUM Growth
+$54.7B
(-0.61%)
Cap. Flow
-$881M
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
14.84%
Holding
1,618
New
74
Increased
558
Reduced
581
Closed
77
Top Buys
| 1 |
MRO
Marathon Oil Corporation
MRO
|
$338M |
| 2 |
NVIDIA
NVDA
|
$77.2M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$58.9M |
| 4 |
Take-Two Interactive
TTWO
|
$56.7M |
| 5 |
Alibaba
BABA
|
$46.3M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
$119M |
| 2 |
Oracle
ORCL
|
$106M |
| 3 |
Allstate
ALL
|
$92.4M |
| 4 |
Qualcomm
QCOM
|
$87.3M |
| 5 |
Marsh & McLennan
MMC
|
$76.3M |
Sector Composition
| 1 | Healthcare | 17.55% |
| 2 | Financials | 15.04% |
| 3 | Technology | 12.33% |
| 4 | Energy | 9.55% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$427B
| $837M | 1.53% | 6,326,351 -444,209 | -7% | -$58.8M |
|
|
2
Oracle
ORCL
$635B
| $829M | 1.52% | 16,531,388 -2,109,386 | -11% | -$106M |
|
3
Abbott
ABT
$231B
| $825M | 1.51% | 16,970,213 -1,455,284 | -8% | -$70.7M |
|
4
Equity Residential
EQR
$25.3B
| $822M | 1.5% | 12,490,913 -439,410 | -3% | -$28.9M |
|
|
5
Quest Diagnostics
DGX
$20.3B
| $810M | 1.48% | 7,288,881 -1,075,030 | -13% | -$119M |
|
6
Bank of New York Mellon
BK
$74.5B
| $805M | 1.47% | 15,782,486 -702,737 | -4% | -$35.9M |
|
7
Pfizer
PFE
$141B
| $803M | 1.47% | 23,903,742 -780,004 | -3% | -$26.2M |
|
8
Edison International
EIX
$21.6B
| $800M | 1.46% | 10,235,217 -673,278 | -6% | -$52.6M |
|
|
CA
9
DELISTED
CA, Inc.
CA
| $793M | 1.45% | 23,016,047 -709,351 | -3% | -$24.5M |
|
|
10
Allstate
ALL
$53.6B
| $793M | 1.45% | 8,968,676 -1,045,136 | -10% | -$92.4M |
|
11
Merck
MRK
$210B
| $786M | 1.44% | 12,270,566 -273,178 | -2% | -$17.5M |
|
12
Northrop Grumman
NOC
$84.5B
| $784M | 1.43% | 3,055,002 -145,025 | -5% | -$37.2M |
|
13
Waste Management
WM
$91.2B
| $784M | 1.43% | 10,690,903 -446,672 | -4% | -$32.8M |
|
14
CVS Health
CVS
$92.8B
| $781M | 1.43% | 9,703,401 -48,860 | -0.5% | -$3.93M |
|
15
Truist Financial
TFC
$60.4B
| $778M | 1.42% | 17,133,475 +291,257 | +2% | +$13.2M |
|
|
RTN
16
DELISTED
Raytheon Company
RTN
| $774M | 1.42% | 4,795,104 -309,345 | -6% | -$50M |
|
|
DD
17
DELISTED
Du Pont De Nemours E I
DD
| $770M | 1.41% | 9,540,096 -449,895 | -5% | -$36.3M |
|
|
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
| $758M | 1.39% | 11,880,919 +922,406 | +8% | +$58.9M |
|
19
Cisco
CSCO
$274B
| $755M | 1.38% | 24,109,431 -652,273 | -3% | -$20.4M |
|
20
Cardinal Health
CAH
$35.5B
| $753M | 1.38% | 9,659,975 -208,144 | -2% | -$16.2M |
|
|
21
Marsh & McLennan
MMC
$101B
| $751M | 1.37% | 9,632,690 -978,642 | -9% | -$76.3M |
|
22
Chevron
CVX
$324B
| $750M | 1.37% | 7,187,057 +99,802 | +1% | +$10.4M |
|
23
AT&T
T
$209B
| $745M | 1.36% | 19,735,452 +118,276 | +0.6% | +$4.46M |
|
24
Intel
INTC
$107B
| $737M | 1.35% | 21,836,205 -27,323 | -0.1% | -$922K |
|
25
Mondelez International
MDLZ
$79.5B
| $726M | 1.33% | 16,799,699 -433,173 | -3% | -$18.7M |
|